Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #403066 on Anavex Life Sciences Corp (AVXL)
WolfofMia
02/13/23 7:16 AM
#403067 RE: Investor2014 #403066
The trial met both its co-primary and key secondary endpoints, showing statistically significant and clinically meaningful improvement in cognition and function as measured by ADAS-Cog, ADCS-ADL, and CDR-SB, respectively.
kevindenver
02/13/23 8:44 AM
#403083 RE: Investor2014 #403066